Evidence map›Paper›PMID 40161171›Full record

ArticleCureus2025

Computed Tomography Pulmonary Angiography (CTPA) Utilization in Suspected Pulmonary Embolism Patients Based on Age-Adjusted D-dimer Thresholds and Pulmonary Embolism Rule-Out Criteria (PERC) Score: A Retrospective Analysis.

Ahmed Malik, Mohammed Ahmed, Sara Hamid, Eiman Ahmed, Moazzma Ifzaal

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed MalikAcute Internal Medicine, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Mohammed AhmedAcute Internal Medicine, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Sara HamidAcute Internal Medicine, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Eiman AhmedAcute Internal Medicine, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Moazzma IfzaalAcute Internal Medicine, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computed tomography pulmonary angiography (CTPA) is the gold standard for diagnosing pulmonary embolism (PE), but its overuse can lead to unnecessary radiation exposure and increased healthcare costs. This clinical audit evaluated adherence to National Institute for Health and Care Excellence (NICE) guidelines (NG 158) for CTPA utilization in suspected PE cases. A retrospective analysis of 164 patients at the Royal Stoke University Hospital assessed the application of the pulmonary embolism rule-out criteria (PERC) score in patients aged 18-49 and age-adjusted D-dimer thresholds in those aged 50 and above. Findings revealed that only 14.6% of CTPA scans confirmed PE. Notably, 46.93% of patients under 50 with a PERC score of 0 underwent unnecessary imaging, and 13 patients aged 50 and above with normal age-adjusted D-dimer levels had CTPA, all yielding negative results. These findings indicate a significant overuse of CTPA in low-risk patients. Improving adherence to risk stratification tools through clinician education, decision-support tools, and increased awareness could reduce unnecessary imaging, minimize radiation exposure, and optimize healthcare resource utilization.

Indexed as

age-adjusted d-dimerclinical auditctpanice guidelinesperc scorepulmonary embolism

Identifiers

PMID40161171
PMCPMC11954363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.